Patent · US Active

Pyrazolopyrimidine derivatives

US10604525B2 · kind B2 · utility

2Cited by

0References

16Claims

0Family size

Assignee

BAYAL ANIMAL HEALTH GMBH · DE

Inventors

Adeline Köhler · Langenfeld, DE
Claudia WELZ · Goldkronach, DE
Kirsten BÖRNGEN · Neunburg vorm Wald, DE
Daniel KULKE · Leverkusen, DE
Thomas ILG · Monheim, DE
Johannes Köbberling · Neuss, DE
Walter Hubsch · Wuppertal, DE
Hans-Georg Schwarz · Dorsten, DE
Ulrich Görgens · Ratingen, DE
Ulrich Ebbinghaus-Kintscher · Dortmund, DE
Maike Hink · Markgröningen, DE
Dirk Nennstiel · Neunburg vorm Wald, DE
Klaus Raming · Leverkusen, DE
Martin Adamczewski · Cologne, DE
Claudia Böhm · Hannover, DE
Nils Griebenow · Milford, US
Wei Zhuang · Monheim, DE

Key dates

Filing date	Apr 10, 2017
Grant date	Mar 31, 2020
Priority date	—
Expiry date	Apr 10, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/02
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention covers Pyrazolopyrimidine compounds of general formula (I), in which n, o, X, Y, R, Q, R1, R2, R3 and R4 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.